TRISORALEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trisoralen, and what generic alternatives are available?
Trisoralen is a drug marketed by Valeant Pharm Intl and is included in one NDA.
The generic ingredient in TRISORALEN is trioxsalen. There are two drug master file entries for this compound. Additional details are available on the trioxsalen profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRISORALEN?
- What are the global sales for TRISORALEN?
- What is Average Wholesale Price for TRISORALEN?
Summary for TRISORALEN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| Patent Applications: | 3,557 |
| DailyMed Link: | TRISORALEN at DailyMed |
US Patents and Regulatory Information for TRISORALEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | TRISORALEN | trioxsalen | TABLET;ORAL | 012697-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
